Sarcoma: open trials in Chile

• NCT06395103

  Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC

  Hospital Clínico Regional Dr. Guillermo Grant Benavente ( Site 1881), Concepción · Hospital Luis Calvo Mackenna ( Site 1879), Santiago · Hospital Carlos Van Buren ( Site 1880), Valparaíso

  Registry updated 2026-10-30

• NCT06345729

  A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  FALP-UIDO ( Site 0501), Santiago · Orlandi Oncologia-Oncology ( Site 0503), Santiago · Centro de Oncología de Precisión ( Site 0502), Santiago · Bradfordhill-Clinical Area ( Site 0504), Santiago · Clinica Universidad Catolica del Maule-Oncology ( Site 0500), Talca

  Registry updated 2026-10-26

• NCT07252739

  KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

  Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC

  Fundacion Arturo Lopez Perez ( Site 0167), Santiago · Centro de Oncología de Precisión ( Site 0160), Santiago · Bradfordhill ( Site 0168), Santiago

  Registry updated 2026-09-02

All Sarcoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error